Financial Data and Key Metrics Changes - The company reported gross revenues of BRL 19.5 billion in 2025, an 8% increase year-over-year [9][33] - Adjusted net income for Q4 2025 was BRL 1.3 billion, and BRL 5.2 billion for the full year, representing a 15% expansion year-over-year [10][38] - The return on equity (ROE) reached 23.9% in 2025, a 94 basis points increase compared to 2024 [11][40] - The year-end BIS ratio was 20.4%, indicating a strong capital position [11][41] Business Line Data and Key Metrics Changes - Retail revenues totaled BRL 3.9 billion in Q4 2025, up 8% year-over-year, and BRL 14.6 billion for the full year, also an 8% increase [33][34] - Corporate and issuer services revenue reached BRL 895 million in Q4 2025, a 49% increase year-over-year, and BRL 2.7 billion for the full year, up 19% compared to 2024 [35][36] - The wholesale bank has become a key pillar of the company's strategy, integrating investment banking and institutional access [27][28] Market Data and Key Metrics Changes - Total client assets, including AUM and AUA, reached BRL 2.1 trillion, representing a 22% growth year-over-year [21] - Retail net new money was BRL 20 billion, while corporate and institutional net new money totaled BRL 12 billion, amounting to BRL 32 billion for the period [21][22] - The company faced challenges with small and medium enterprises withdrawing BRL 3 billion in investments, but individual client inflows totaled BRL 23 billion [22] Company Strategy and Development Direction - The company aims to become Brazil's leading investment platform by 2033, focusing on market share and democratizing wealth planning for retail clients [51][52] - A third wave of strategy is being implemented to enhance service models and client segmentation, moving away from a product-driven approach [52][54] - Continued investments in technology and advisor training are expected to drive growth and improve service quality [18][45] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in capturing future opportunities despite a challenging environment for 2026 [7][22] - The company is focused on maintaining strong returns while expanding its credit offerings and addressing the needs of small and medium enterprises [29][45] - Concerns were raised regarding recent irregularities in the financial system, with a commitment to support structural improvements [46][48] Other Important Information - The company returned BRL 2.4 billion to shareholders through dividends and buybacks in 2025 [39] - Adjusted EPS for Q4 was BRL 2.56, growing 15% year-over-year, and for the full year, it reached BRL 9.81, an 18% increase [40][41] - The company is launching new products, including a proprietary dollar-backed stablecoin and expanding its insurance offerings [23][24] Q&A Session Summary Question: Ambition to become Brazil's leading investment platform by 2033 - The company aims for market share leadership by 2033, with plans indicating the ability to achieve this in seven years through democratizing wealth planning and enhancing service models [51][52] Question: Impact of entry into the controlling group - The CEO stated that there is no change in management style or operations, emphasizing stronger alignment among executives [54] Question: Impact of CVM's recommendation on RLP business - Management views the removal of caps on orders as positive for the RLP business, enhancing market-making capabilities [60][62] Question: Tax increases and their relation to revenue mix - The CFO clarified that the increase in taxes is due to the revenue mix, particularly from corporate and issuer services, and not related to structural changes [63][64] Question: Strategy to capture volumes from Banco Master reimbursements - The company is seeing a significant inflow from Banco Master, retaining over 85% of the funds, and will disclose net new money figures in Q1 [68][69]

Toast (NYSE:TOST) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsAdam Frisch - Senior Managing DirectorAman Narang - CEODominic Ball - Equity Research AssociateElena Gomez - CFOMatt Coad - DirectorMichael Senno - Senior VP of FinanceTimothy Chiodo - Managing DirectorWill Nance - VPConference Call ParticipantsDan Dolev - Senior AnalystJosh Baer - Executive Director and Software Equity Research AnalystTien-tsin Huang - Senior AnalystOperatorGood afternoon. My name is Tiffany, and I wi ...

Financial Data and Key Metrics Changes - In Q4 2025, total revenue grew 14% year-over-year to $44.6 million, with a sequential increase of 16% [7][27] - For the full year 2025, total revenue reached $160 million, representing a 4% growth over 2024 [7][30] - Non-GAAP gross margin improved to 40% in Q4 2025, up from 31% in Q4 2024, and for the full year, it was also 40%, compared to 33% in 2024 [31][24] - Non-GAAP operating expenses decreased to $56.2 million in Q4 2025, down 18% year-over-year, and for the full year, they were $229.9 million, down from $289.2 million in 2024 [32][24] - Cash burn improved from $214 million in 2023 to $105 million in 2025, with approximately $280 million in cash and investments at year-end [25][34] Business Line Data and Key Metrics Changes - Consumable revenue in Q4 2025 increased 15% year-over-year to $21.6 million, driven by an increase in the installed base and consistent system utilization [27][28] - Instrument revenue rose 13% in Q4 to $17.3 million, primarily due to increased shipments of Vega systems [28] - For the full year 2025, consumables revenue increased 16% to $82 million, while instrument revenue decreased 18% to $53.8 million [30] Market Data and Key Metrics Changes - Revenue from the Americas increased 3% to $20.7 million in Q4 2025, while Asia Pacific revenue rose 4% to $9.3 million, and EMEA revenue surged 45% to $14.6 million [29][10] - EMEA's strong growth was attributed to increased Vega instrument shipments and higher Revio consumables as clinical customers transitioned from pilot testing to broader adoption [11][29] Company Strategy and Development Direction - The company aims to enhance the economics of HiFi sequencing through the launch of SparkNex and multi-use smart cells, targeting increased market penetration [37] - Focus areas include accelerating clinical adoption in rare disease, oncology, and carrier screening, as well as enabling population-scale sequencing studies [37] - The company plans to leverage AI to unlock biological insights from multi-omic HiFi data [37] Management's Comments on Operating Environment and Future Outlook - Management anticipates continued growth in clinical markets, particularly in rare disease and whole genome sequencing, despite a challenging academic funding environment [11][54] - The outlook for 2026 projects revenue between $165 million and $180 million, representing approximately 8% growth at the midpoint [34] - Management expects non-GAAP gross margin to improve by 100-400 basis points in 2026, driven by a higher consumables mix and the introduction of SparkNex [35] Other Important Information - The company sold its short-read sequencing assets for net proceeds of approximately $48 million, strengthening its balance sheet and extending its cash runway [26] - The company is committed to supporting existing customers during the transition period following the divestment of short-read assets [26] Q&A Session Summary Question: What should we expect for Revio pull-through and consumables growth? - Management expects SparkNex to lower sample costs, likely increasing utilization and expanding market share, while maintaining pull-through in the range of $225K-$250K [41][43] Question: What is the outlook for clinical growth outside the U.S.? - Management sees strong growth in clinical markets, particularly in EMEA, with significant movement from pilot phases to production [53] Question: Where are the biggest opportunities for OpEx reduction? - Management plans to focus on managing G&A expenses and R&D while continuing to reduce production costs through insourcing [66][68] Question: What impact will the short-read divestment have on costs? - Management indicated that while there won't be substantial additional costs taken out immediately, the divestment will provide a tailwind to gross margin over time [72] Question: How does long-read sequencing compare to standard care in terms of cost? - Long-read sequencing is expected to provide better diagnostic yield, faster turnaround times, and lower overall costs by consolidating multiple tests into one [74]

Pacific Biosciences of California (NasdaqGS:PACB) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsChristian Henry - CEODan Brennan - Managing DirectorJim Gibson - CFOKelly Guru - Director of Investors RelationsConference Call ParticipantsDavid Westenberg - Managing Director and Equity Research AnalystDoug Shenko - Senior AnalystJack Meehan - Equity Research AnalystKyle Mixon - Equity Research AnalystMason Carrico - Equity Research AnalystSubbu Nambi - Managing Director and Healthcare ...

HA Sustainable Infrastructure Capital (NYSE:HASI) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsAaron Chew - SVP of Investor RelationsCharles Melko - CFODavis Sunderland - Senior Research AssociateJeff Lipson - President and CEOMarc Pangburn - Chief Revenue and Strategy OfficerPraneet Satish - Equity Research AssociateSusan Nickey - Chief Client OfficerConference Call ParticipantsBrian Lee - Clean Technology AnalystChris Dendrinos - Director and Senior US Clean Energy AnalystJeff O ...

Electrovaya (NasdaqCM:ELVA) Q1 2026 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsColin Rusch - Managing Director and Head of Sustainable Growth and Resource Optimization ResearchDaniel Magder - Managing Director of Investment BankingGraham Tanaka - PresidentJohn Gibson - CFORaj DasGupta - CEOConference Call ParticipantsAmit Dayal - Managing Director and Senior Technology AnalystCraig Irwin - Managing Director and Senior Research AnalystEric Stine - Senior Research AnalystJeffrey Campbell ...

Electrovaya (NasdaqCM:ELVA) Q1 2026 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsColin Rusch - Managing Director and Head of Sustainable Growth and Resource Optimization ResearchDaniel Magder - Managing Director of Investment BankingGraham Tanaka - PresidentJohn Gibson - CFORaj DasGupta - CEOConference Call ParticipantsAmit Dayal - Managing Director and Senior Technology AnalystCraig Irwin - Managing Director and Senior Research AnalystEric Stine - Senior Research AnalystJeffrey Campbell ...

Financial Performance - Total revenue decreased approximately $3 million or 2.7% to approximately $108.5 million for the quarter ended December 31, 2025, compared to revenue of approximately $111.5 million in the prior year period [4] - Operating income increased approximately $2.7 million or 352.9% to $3.5 million for the first quarter, compared with operating income of approximately $800,000 in the prior year period [9] - Adjusted EBITDA for the first quarter was approximately $7.8 million, an increase of approximately $2 million or 35.7% compared to $5.7 million in the prior year period [10] Business Segment Performance - Retail-Flooring segment revenue for the first quarter was approximately $25.3 million, down $6.4 million or 20.2% compared to $31.7 million in the prior year period, primarily due to changes in store footprint and softness in the housing market [5] - Flooring Manufacturing segment revenue for the first quarter was approximately $28.9 million, a decrease of approximately $300,000 or 1.1% compared to approximately $29.2 million in the prior year period [6] - Steel Manufacturing segment revenue for the first quarter was approximately $31.9 million, a decrease of approximately $1.4 million or 4.3% compared to approximately $33.3 million in the prior year period [7] Market Conditions - The decline in revenue was primarily attributable to a $7.1 million decline in the Retail-Flooring and Steel Manufacturing segments, partially offset by a $4.1 million increase in the Retail-Entertainment and Flooring Manufacturing segments [4] - The company experienced sustained softness in new home construction and home refurbishment markets, which continued to weigh on the retail flooring segment [3] Company Strategy and Industry Competition - The company is rolling out a comprehensive strategy to integrate AI across the business units to modernize operations and improve efficiency [11] - The integration of AI alongside robotics and data analytics aims to reinforce cost discipline that supports the long-term strategy [12] Management Commentary on Operating Environment and Future Outlook - Management noted that despite a challenging housing market backdrop, the company delivered a solid first quarter marked by meaningful operating improvements across the businesses [11] - The company successfully refinanced one of its credit facilities in the steel manufacturing segment, strengthening its balance sheet and enhancing its ability to support future growth [3] Other Important Information - Gross profit was approximately $35.4 million for the first quarter, essentially unchanged compared to the prior year period, but gross margin increased by 90 basis points to 32.6% [8] - General and administrative expense decreased approximately $2.2 million or 7.4% to approximately $27.8 million, driven primarily by targeted cost reduction initiatives [9] - Total cash availability at the end of the first quarter was $38.7 million, consisting of cash on hand of $15.1 million and availability under various lines of credit of $23.6 million [11] Q&A Session Summary Question: Are there any questions from the participants? - There were no questions from the participants during the Q&A session [13]

Ultragenyx Pharmaceutical (NasdaqGS:RARE) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsEmil Kakkis - CEOEric Crombez - CMOErik Harris - CCOHoward Horn - CFOJoshua Higa - VP of Investor RelationsLydia Edelman - Biotech Equity Research AssociateMaxwell Skor - Vice President, Biotech Equity ResearchPriyanka Nagpal - Vice President - Change ManagementRick Miller - Vice President, Biotech Equity ResearchTara Ahmad - AVP, Testing Specialist IWill Soghikian - Research AssociateYigal Dov ...

Financial Data and Key Metrics Changes - In Q4 2025, Roku achieved platform revenue growth of 18%, surpassing $1.2 billion, with Adjusted EBITDA of $169 million and net income of $80 million, all records for the company [11][12] - For the full year, platform revenue also grew 18%, with Adjusted EBITDA of $421 million, representing a margin expansion of 255 basis points, and free cash flow of $484 million, over 100% year-over-year growth [12][13] - The outlook for Q1 2026 indicates platform revenue growth of over 21% and 18% for the full year, with full-year adjusted EBITDA guidance of $635 million, representing over 50% year-over-year growth [12][13] Business Line Data and Key Metrics Changes - The advertising segment saw deepened integration with leading demand-side platforms, enhancing measurement and performance capabilities, contributing to the overall revenue growth [9][10] - Q4 2025 was the biggest quarter ever for premium subscription net adds, with plans to add more tier one partners and roll out bundles [9][10] Market Data and Key Metrics Changes - Roku is positioned in over half of U.S. broadband households, with nearly half of all TV streaming occurring on its platform, indicating strong market penetration [18][92] - Internationally, Roku is focusing on monetization in Canada and Mexico, where it has significant scale, while still building scale in Brazil and other Latin American countries [42][44] Company Strategy and Development Direction - Roku's strategy includes broadening and diversifying retail distribution, optimizing investments across retail and OEM partners, and expanding its licensing agreements with major TV manufacturers [15][17] - The company is leveraging AI to enhance content discovery, engagement, and monetization opportunities, viewing it as a significant opportunity rather than a disruptor [24][26][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining double-digit platform revenue growth while continuing to grow profitability, with a strong focus on operational efficiency and maintaining low cash taxes due to a deferred tax asset [13][19] - The company anticipates that international markets will become a larger percentage of overall platform revenue over time, with ongoing efforts to monetize subscriptions and advertising [44][46] Other Important Information - Roku has a strong free cash flow position, with plans to achieve over $1 billion in free cash flow by the end of 2028 [13][19] - The company is actively investing in its advertising platform, including the launch of Ads Manager, which targets small and medium-sized businesses [66][70] Q&A Session Summary Question: Can you help bridge the Q1 revenue outlook of over 21% growth to the full year outlook of about 18% growth? - Management explained that Q1 has an easier comp from the previous year and includes the full benefit of the Frndly acquisition, with stronger visibility into Q1 compared to the second half of the year [14][15] Question: Can you comment on your retail distribution strategy for 2026? - Management stated that they are focused on broadening retail distribution and optimizing investments, with expansions at Best Buy and Target, and plans to increase sales of first-party TVs after shifting production to Mexico [15][17] Question: How do you think AI could impact the streaming landscape? - Management expressed excitement about AI reducing content costs, which would increase engagement on the platform, and highlighted its integration across the technology stack to improve discovery and monetization [24][26][28] Question: How is the third-party ad demand partnership with Amazon impacting the business? - Management indicated that it is early days for the Amazon partnership, but they are optimistic about its potential as it ramps up, and they are integrating with multiple DSPs to enhance performance [33][35] Question: Can you discuss the international viewership and monetization opportunities? - Management noted that they are seeing scale in Canada and Mexico, with a focus on monetization strategies, while Brazil is still in the scale-building phase [42][44] Question: How do you think about the balance between performance-oriented advertising and maintaining high-quality advertisers? - Management emphasized their ability to serve both high-end clients and performance-oriented advertisers, leveraging their unique position in the CTV landscape [62][66]